Back to Agenda
Session 1 Track A: The Patient Experience with Digital Technology
Session Chair(s)
Courtney Granville, PhD, MPH
Chief Scientific Officer
GO2 For Lung Cancer, United States
Digital devices for clinical trials are tested thoroughly by device manufacturers to ensure they work - but will they work for YOUR patients in YOUR trial? This session explores "digital experience testing," where devices are tested by the target patient population in ways that mirror their use in your actual trial. We will outline essential steps to gaining valuable insights into how patients experience the use of the device, and whether clinical data will be collected accurately and consistently. Our panel will present case studies where sponsors learned that device use would positively or negatively impact recruitment or retention, and where device manufacturers learned of changes that needed to be made for successful implementation in a trial. We'll complete the session by challenging participants to consider optimal ways to assess the patient experience with digital devices in both hybrid and decentralized trials.
Learning Objective : At the conclusion of this session, participants should be able to:
- Identify keys for successful digital experience testing with the target patient population
- Differentiate device company usability testing and patient digital experience testing
- Describe examples of impactful learnings from patient digital experience testing
Speaker(s)
The Patient Experience with Digital Technology
Valerie Powell, MS
CorEvitas, LLC, United States
Chief Patient Officer, CorEvitas and EVP, Patient Experience
Speaker
Glen Wunderlich, PhD
Boehringer Ingelheim, United States
Senior Clinical Program Leader, CNS
Speaker
Amy Mason
United States
Sickle Cell Disease Advocate
Speaker
Madeline Geday
Astellas, United States
Senior Director, DCT Office/COE Patient Centriity
Have an account?